TEMC CNS Co., Ltd.

As of June 30, 2026, TEMC CNS Co., Ltd. carries a market capitalization of 56.90B, placing it among publicly traded companies globally. Its enterprise value stands at 69.31B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

TEMC CNS Co., Ltd.'s next confirmed earnings release is scheduled for November 12, 2026.

As of June 30, 2026, TEMC CNS Co., Ltd. has 9.40M shares outstanding.

As of June 30, 2026, TEMC CNS Co., Ltd. trades at a trailing price-to-earnings ratio of 41.99. The price-to-sales ratio is 0.37, and the price-to-book ratio stands at 0.51.

As of June 30, 2026, TEMC CNS Co., Ltd. trades at an EV/EBITDA multiple of 12.39 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.43 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 69.31B versus a market cap of 56.90B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, TEMC CNS Co., Ltd. maintains a current ratio of 1.59, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 28.84, indicating elevated leverage, while an interest coverage ratio of 7.21 demonstrates adequate ability to service its debt obligations.

Over the twelve months ended June 30, 2026, TEMC CNS Co., Ltd. posted a return on equity (ROE) of 1.27, showing how much profit the company earns on every dollar of shareholder capital. Return on assets (ROA) stands at 0.79, measuring how efficiently the asset base is converted into earnings. The company generates approximately 1.01B in revenue per employee across its workforce of 161.25, a quick read on workforce productivity versus industry peers. Inventory turnover of 6.00 indicates how many times TEMC CNS Co., Ltd. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, TEMC CNS Co., Ltd. recorded an income tax benefit of -566.73M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. Taxes are levied on pretax income of 1.49B, leaving 1.41B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 23, 2026, TEMC CNS Co., Ltd.'s stock has declined approximately 18.40% over the past 52 weeks. The 50-day moving average sits at 6,121.60, while the 200-day moving average is 6,614.28.

Over the twelve months ended June 30, 2026, TEMC CNS Co., Ltd. generated 162.12B in revenue and converted that into 1.41B in net income, yielding earnings per share of 209.47. EBITDA reached 5.60B, while operating income came in at -1.55B.

As of June 30, 2026, TEMC CNS Co., Ltd. holds 25.28B in cash and equivalents against 33.27B in total debt, resulting in a net debt position of 6.92B. Total book value stands at 110.97B, with working capital of 46.82B providing operational flexibility.

TEMC CNS Co., Ltd. produced 16.28B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -5.75B in capital expenditures, free cash flow totaled 10.53B - equivalent to 1,073.22 per share.

Over the twelve months ended June 30, 2026, TEMC CNS Co., Ltd. posted a gross margin of 11.30, reflecting its pricing power and cost economics. The operating margin of -0.95 and net profit margin of 0.87 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, TEMC CNS Co., Ltd. paid dividends of - - per share. The dividend payout ratio of - - indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 17.74, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield is negative at -12.61, meaning TEMC CNS Co., Ltd. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, TEMC CNS Co., Ltd. has an Altman Z-Score of 2.29, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.